[ 9 ] Goodrich LV, Milenkovic L, Higgins KM, et al. Altered neural cell fates and medulloblastoma in mouse patched mutants[J]. Science, 1997, 277(5329): 1109-1113.
[2]
Smyth I, Narang MA, Evans T, et al. Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32 [J]. Hum Mol Genet, 1999, 8(2): 291-297.
[3]
Lee Y, Miller HL, Russell HR, et al. Patched2 modulates tumorigenesis in patched1 heterozygous mice[J]. Cancer Res, 2006, 66(14): 6964-6971.
[4]
Reifenberger J, Woher M, Weber RG, et a1. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system [J]. Cancer Res, 1998, 58(9): 1798-1803.
[5]
Taylor MD, Liu L, Raffel C, et al. Mutations in SUFU predispose to medulloblastoma [J]. Nat Genet, 2002, 31(3): 306-310.
Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot’s syndrome [J]. N Engl J Med, 1995, 332(13): 839-847.
[8]
Baeza N, Masuoka J, Kleihues P, et al. AXIN1 mutations but not deletions in cerebellar medulloblastomas [J]. Oncogene, 2003, 22(4): 632-636.
[9]
Zhang P, Li H, WuM L, et al. c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells[J]. J Neurooncol, 2006, 80(2): 123-131.
[10]
Fan X, Mikolaenko I, Elhassan I, et al. Notch1 and notch2 have opposite effects on embryonal brain tumor growth[J]. Cancer Res, 2004, 64(21): 7787-7793.
[11]
Fan X, Matsui W, Khaki L, et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors[J]. Cancer Res, 2006, 66(15): 7445-7452.
[12]
Knoepfler PS, Kenney AM. Neural precursor cycling at sonic speed: N-Myc pedals, GSK-3 brakes[J]. Cell Cycle, 2006, 5(1): 47-52.
[13]
Rao G, Pedone CA, Valle LD, et al. Sonic hedgehog and insulinlike growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice[J]. Oncogene, 2004, 23(36): 6156-6162.
[14]
Jessica MY, Curran T. The Hedgehog’s tale: developing strategies for targeting cancer[J]. Nat Rev Cancer, 2011, 11(7): 493-501.
[15]
Rudin CM, Hann CL, Laterra J, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449[J]. N Engl J Med, 2009, 361(12): 1173-1178.
[16]
Zhang P, Li H, Wu ML, et al. c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells[J]. J Neurooncol, 2006, 80(2): 123-131.
[17]
Wang Q, Li H, Liu N, et al. Correlative analyses of notch signaling with resveratrol-induced differentiation and apoptosis of human medulloblastoma cells[J]. Neurosci Lett, 2008, 438(2): 168-173.
[18]
Wen S, Li H, Wu ML, et al. Inhibition of NF-κB signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation[J]. J Neurooncol, 2011, 104(1): 169-177
[19]
Beauchamp EM, Ringer L, Bulut G, et al. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway[J]. J Clin Invest, 2011, 121(1): 148-160.
[20]
Kim J, Lee JJ, Kim J, et al. Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector[J]. Proc Natl Acad Sci USA, 2010, 107(30): 13432-13437.
[21]
Raju GP. Arsenic: a potentially useful poison for Hedgehog-driven cancers[J]. J Clin Invest, 2011, 121(1): 14-16.
[22]
Favretto ME, Marouf S, Ioannou P. Arsonoliposomes for the Potential Treatment of Medulloblastoma[J]. Pharm Res, 2009, 26(10): 2237-2246.
[ 3 ] Gibson P, Tong Y, Robinson G, et al. Subtypes of medulloblastoma have distinct developmental origins[J]. Nature, 2010, 468(7327): 1095-1099.
[25]
[ 4 ] Visvader JE. Cells of origin in cancer[J]. Nature, 2011, 469(7330): 314-322.
[26]
[ 5 ] Polkinghorn WR, Tarbell NJ. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification[J]. Nat Rev Clin Oncol, 2007, 4(5): 295-304.
[27]
[ 6 ] Gailani MR, Bale SJ, Leffell DJ, et al. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9[J]. Cell, 1992, 69(1): 111-117.
[28]
[ 7 ] Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome[J]. Am J Med Genet, 1997, 69(3): 299-308.
[29]
[ 8 ] Raffel C, Jenkins RB, Frederick L, et al. Sporadic medulloblastomas contain PTCH mutations [J]. Cancer Res, 1997, 57(5): 842-845.
[30]
Browd SR, Kenney AM, Gottfried ON, et al. N-myc can substitute for insulinlike growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma[J]. Cancer Res, 2006, 66(5): 2666-2672.
